Home
Random
Nearby
Log in
Settings
Donate
About Wikidata
Disclaimers
Search
(Q32064646)
Watch
English
Pharmacologic treatment of generalized anxiety disorder
scientific article
In more languages
edit
Statements
instance of
scholarly article
1 reference
stated in
Europe PubMed Central
PubMed ID
11225503
retrieved
6 July 2017
review article
1 reference
stated in
Europe PubMed Central
title
Pharmacologic treatment of generalized anxiety disorder
(English)
1 reference
stated in
Europe PubMed Central
PubMed ID
11225503
retrieved
6 July 2017
main subject
generalized anxiety disorder
1 reference
based on heuristic
inferred from title
author name string
Brawman-Mintzer O
series ordinal
1
1 reference
stated in
Europe PubMed Central
PubMed ID
11225503
retrieved
6 July 2017
publication date
1 March 2001
1 reference
stated in
Europe PubMed Central
PubMed ID
11225503
retrieved
6 July 2017
published in
Psychiatric Clinics of North America
1 reference
stated in
Europe PubMed Central
PubMed ID
11225503
retrieved
6 July 2017
volume
24
1 reference
stated in
Europe PubMed Central
PubMed ID
11225503
retrieved
6 July 2017
page(s)
119-137
1 reference
stated in
Europe PubMed Central
PubMed ID
11225503
retrieved
6 July 2017
issue
1
1 reference
stated in
Europe PubMed Central
PubMed ID
11225503
retrieved
6 July 2017
cites work
A double-blind comparison of buspirone, clobazam, and placebo in patients with anxiety treated in a general practice setting
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970209-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Somatic symptoms in generalized anxiety disorder with and without comorbid psychiatric disorders.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970209-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Psychiatric comorbidity in patients with generalized anxiety disorder.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970209-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Treatment outcomes for primary care patients with major depression and lifetime anxiety disorders
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970209-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Serotonergic studies in patients with affective and personality disorders. Correlates with suicidal and impulsive aggressive behavior
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970209-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
A phase II multicenter dose-finding, efficacy and safety trial of ipsapirone in outpatients with generalized anxiety disorder.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970209-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Efficacy, safety, and tolerability of venlafaxine extended release and buspirone in outpatients with generalized anxiety disorder
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970209-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Assessment of the Efficacy of Buspirone in Patients Affected by Generalized Anxiety Disorder, Shifting to Buspirone From Prior Treatment with Lorazepam
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970209-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Prior benzodiazepine use and buspirone response in the treatment of generalized anxiety disorder
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970209-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Alprazolam versus buspirone in the treatment of outpatients with generalized anxiety disorder
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970209-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Recent clinical trials of hydroxyzine in generalized anxiety disorder.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970209-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Comparison of withdrawal of buspirone and diazepam: a placebo controlled study
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970209-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Use of buspirone in patients with generalized anxiety disorder and coexisting depressive symptoms. A meta-analysis of eight randomized, controlled studies
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970209-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
The comparative efficacy of buspirone and diazepam in the treatment of anxiety
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970209-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Mirtazapine in major depression with comorbid generalized anxiety disorder
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970209-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Anxious and nonanxious depression
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970209-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Alprazolam withdrawal in patients with panic disorder and generalized anxiety disorder: vulnerability and effect of carbamazepine
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970209-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
The relationship between anxiety disorders and alcohol use disorders: a review of major perspectives and findings.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970209-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
SSRI-induced extrapyramidal side-effects and akathisia: implications for treatment.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970209-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Buspirone and lorazepam in the treatment of generalized anxiety disorder in outpatients
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970209-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Limitations on the use of benzodiazepines in anxiety and insomnia: are they justified?
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970209-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
A multicentre double-blind comparison of hydroxyzine, buspirone and placebo in patients with generalized anxiety disorder
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970209-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
A multicentre double-blind comparative trial of fluvoxamine versus lorazepam in mixed anxiety and depression treated in general practice
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970209-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Alcohol and depression in panic disorder
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970209-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Recent developments in the psychopharmacology of anxiety disorders
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970209-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Long-term follow-up of generalized anxiety disorder
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970209-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Evaluation of the ratings comprising the associated symptom criterion of DSM-III-R generalized anxiety disorder.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970209-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Quality of life and psychiatric morbidity in panic disorder and generalized anxiety disorder
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970209-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
The impact of comorbid mood and personality disorders in the cognitive-behavioral treatment of panic disorder
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970209-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Female sexual dysfunction associated with antidepressant administration: a randomized, placebo-controlled study of pharmacologic intervention
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970209-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Diagnosis and outcome: depression and anxiety in a general population
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970209-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
The Prognosis of Anxiety Neurosis
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970209-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Common mental disorders and disability across cultures. Results from the WHO Collaborative Study on Psychological Problems in General Health Care
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970209-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Buspirone: anxiolytic?
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970209-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Evaluation of buspirone as an antianxiety agent: buspirone and diazepam versus placebo
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970209-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Gabapentin as a potential treatment for anxiety disorders.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970209-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Long-term buspirone therapy for chronic anxiety: a multicenter international study to determine safety.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970209-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Effect of personality disorders on the treatment outcome of axis I conditions: an update.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970209-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Relapse after Short-Term Drug Therapy in Neurotic Outpatients
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970209-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
A controlled clinical trial of alprazolam for the treatment of anxiety
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970209-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Antidepressants for the treatment of generalized anxiety disorder. A placebo-controlled comparison of imipramine, trazodone, and diazepam
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970209-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
The Clinical Course and Long-Term Management of Generalized Anxiety Disorder
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970209-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Long-term Treatment of Anxiety and Risk of Withdrawal
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970209-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Gepirone and diazepam in generalized anxiety disorder: a placebo-controlled trial
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970209-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Alprazolam and oxazepam in the treatment of anxious out-patients with depressive symptoms: a double-blind multicenter study
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970209-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Paroxetine efficacy in the treatment of generalized anxiety disorder
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970209-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Clinical aspects of chronic use of alprazolam and lorazepam.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970209-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Effects of SSRIs on sexual function: a critical review
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970209-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
A clinical trial of buspirone and diazepam in the treatment of generalized anxiety disorder.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970209-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
The impact of clinically diagnosed personality disorders on acute and one-year outcomes of electroconvulsive therapy
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970209-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Resistance to the anti-anxiety effect of buspirone in patients with a history of benzodiazepine use
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970209-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Once-daily venlafaxine extended release (XR) compared with fluoxetine in outpatients with depression and anxiety. Venlafaxine XR 360 Study Group
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970209-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Cost of anxiety disorders: impact of comorbidity.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970209-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
International study of expert judgment on therapeutic use of benzodiazepines and other psychotherapeutic medications: VI. Trends in recommendations for the pharmacotherapy of anxiety disorders, 1992-1997.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970209-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
DSM-III-R generalized anxiety disorder in the National Comorbidity Survey.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970209-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
A 5-Year Follow-up Study of Generalized Anxiety Disorder and Panic Disorder
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970209-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Phenomenology and course of generalised anxiety disorder.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970209-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Identifiers
DOI
10.1016/S0193-953X(05)70209-4
1 reference
stated in
Europe PubMed Central
PubMed ID
11225503
retrieved
6 July 2017
PubMed ID
11225503
1 reference
stated in
Europe PubMed Central
PubMed ID
11225503
retrieved
6 July 2017
Sitelinks
Wikipedia
(0 entries)
edit
Wikibooks
(0 entries)
edit
Wikinews
(0 entries)
edit
Wikiquote
(0 entries)
edit
Wikisource
(0 entries)
edit
Wikiversity
(0 entries)
edit
Wikivoyage
(0 entries)
edit
Wiktionary
(0 entries)
edit
Multilingual sites
(0 entries)
edit